Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2007-08-13 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: FOS-SUR-MER (13270), Bouches-du-Rhone
SELARL PHARMACIE DES CARABINS : revenue, balance sheet and financial ratios
SELARL PHARMACIE DES CARABINS is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in FOS-SUR-MER (13270),
this company of category PME
shows in 2018 a revenue of 2.7 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DES CARABINS (SIREN 499549186)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
2 671 019 €
2 582 114 €
2 592 424 €
Net income
63 410 €
112 311 €
238 177 €
216 005 €
58 371 €
202 239 €
157 321 €
175 150 €
206 616 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
199 827 €
232 115 €
290 519 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
5.9%
6.8%
8.0%
Revenue and income statement
In 2024, SELARL PHARMACIE DES CARABINS generates positive net income of 63 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 207 k€ -> 63 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
63 410 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 8%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 81%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
7.53%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
80.719%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DES CARABINS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
36.927
22.605
11.318
0.323
0.886
5.684
9.44
7.521
7.53
Financial autonomy
66.013
73.462
79.041
86.807
84.238
78.504
77.613
80.036
80.719
Repayment capacity
3.001
2.252
1.35
None
None
None
None
None
None
Cash flow / Revenue
8.542%
7.674%
6.682%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
7.532024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent
In 2024, the debt ratio of SELARL PHARMACIE DES CARA... (7.53) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
80.72%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+7 pts over 3 years
In 2024, the financial autonomy of SELARL PHARMACIE DES CARA... (80.7%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 254.42. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
254.419
Liquidity indicators evolution SELARL PHARMACIE DES CARABINS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
185.002
172.306
149.305
137.566
122.978
171.972
206.061
224.125
254.419
Interest coverage
6.669
5.403
3.805
None
None
None
None
None
None
Sector positioning
Liquidity ratio
254.422024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good+21 pts over 3 years
In 2024, the liquidity ratio of SELARL PHARMACIE DES CARA... (254.42) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 227 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 847 days. Excellent situation: suppliers finance 620 days of the operating cycle (retail model).
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
227 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
847 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE DES CARABINS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
291 622 €
307 349 €
329 684 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
37
34
37
0
0
0
0
0
0
Customer payment term (days)
10
10
10
0
0
0
0
0
227
Supplier payment term (days)
34
41
43
0
0
0
0
0
847
Positioning of SELARL PHARMACIE DES CARABINS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE DES CARABINS is estimated at
885 250 €
(range 616 474€ - 1 324 385€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
616k€885k€1324k€
885 250 €Range: 616 474€ - 1 324 385€
NAF 5 année 2024
Valuation method used
Net Income Multiple
63 410 €
×
14.0x
=885 250 €
Range: 616 474€ - 1 324 385€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DES CARABINS with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DES CARABINS
What is the revenue of SELARL PHARMACIE DES CARABINS ?
The revenue of SELARL PHARMACIE DES CARABINS in 2018 is 2.7 M€.
Is SELARL PHARMACIE DES CARABINS profitable?
Yes, SELARL PHARMACIE DES CARABINS generated a net profit of 63 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE DES CARABINS ?
The headquarters of SELARL PHARMACIE DES CARABINS is located in FOS-SUR-MER (13270), in the department Bouches-du-Rhone.
Where to find the tax return of SELARL PHARMACIE DES CARABINS ?
The tax return of SELARL PHARMACIE DES CARABINS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DES CARABINS operate?
SELARL PHARMACIE DES CARABINS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart